Literature DB >> 8396806

Phosphorylation and dephosphorylation events play critical roles in Sindbis virus maturation.

N Liu1, D T Brown.   

Abstract

We have examined the effects of various inhibitors of protein kinases and phosphatases on Sindbis virus maturation in BHK cells. 2-aminopurine, a nonspecific protein kinase inhibitor, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7), a specific inhibitor of calmodulin/Ca(2+)-dependent protein kinase, and okadaic acid (OKA), a protein phosphatase inhibitor, dose-dependently inhibited Sindbis virus maturation. Although virus production was inhibited, the membrane glycoprotein precursors PE2/E1 were exported from the endoplasmic reticulum and PE2 was converted to E2 at normal kinetic rates. The glycoproteins were delivered to the plasma membrane in conformations which rendered them competent for low pH-mediated cell-cell fusion from within. Electron microscopy showed that in the presence of W-7, virus nucleocapsids were free in the cell cytoplasm, while in the presence of OKA, the nucleocapsids were associated with cell membranes. Metabolic labeling of Sindbis virus-infected cells with [32P]orthophosphate in the presence of OKA resulted in the specific labeling of the PE2/E2 glycoprotein. We have previously shown that the carboxyl terminus of the PE2 glycoprotein is initially buried in cell membranes and is then exposed to the cytoplasm at some later stage in virus maturation. The data shown are consistent with the hypothesis that phosphorylation and dephosphorylation play a critical role in a late stage in Sindbis virus maturation, possibly in releasing of the E2 tail from cell membranes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396806     DOI: 10.1006/viro.1993.1527

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  A single deletion in the membrane-proximal region of the Sindbis virus glycoprotein E2 endodomain blocks virus assembly.

Authors:  R Hernandez; H Lee; C Nelson; D T Brown
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Structures of immature flavivirus particles.

Authors:  Ying Zhang; Jeroen Corver; Paul R Chipman; Wei Zhang; Sergei V Pletnev; Dagmar Sedlak; Timothy S Baker; James H Strauss; Richard J Kuhn; Michael G Rossmann
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

3.  Molecular links between the E2 envelope glycoprotein and nucleocapsid core in Sindbis virus.

Authors:  Jinghua Tang; Joyce Jose; Paul Chipman; Wei Zhang; Richard J Kuhn; Timothy S Baker
Journal:  J Mol Biol       Date:  2011-10-04       Impact factor: 5.469

4.  The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging.

Authors:  Anna K Overby; Ralf F Pettersson; Etienne P A Neve
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  The nucleocapsid-binding spike subunit E2 of Semliki Forest virus requires complex formation with the E1 subunit for activity.

Authors:  B U Barth; H Garoff
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Molecular genetic study of the interaction of Sindbis virus E2 with Ross River virus E1 for virus budding.

Authors:  J Yao; E G Strauss; J H Strauss
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Intracellular posttranslational modifications of S1133 avian reovirus proteins.

Authors:  R Varela; J Martínez-Costas; M Mallo; J Benavente
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 8.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

9.  Effects of anti-E2 monoclonal antibody on sindbis virus replication in AT3 cells expressing bcl-2.

Authors:  P Després; J W Griffin; D E Griffin
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment.

Authors:  P Després; J W Griffin; D E Griffin
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.